| Cited in | Search | Type: | Non-patent literature | Publication information: | [XY] - BENJAMIN L E ET AL, "Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.", THE JOURNAL OF CLINICAL INVESTIGATION JAN 1999 LNKD- PUBMED:9916127, (199901), vol. 103, no. 2, ISSN 0021-9738, pages 159 - 165, XP009133357 [X] 1-3 * Whole document;;; figure 2 * [Y] 4-9 | Type: | Non-patent literature | Publication information: | [Y] - BERGERS GABRIELE ET AL, "Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors", JOURNAL OF CLINICAL INVESTIGATION, AMERICAN SOCIETY FOR CLINICAL INVESTIGATION, US LNKD- DOI:10.1172/JCI200317929, (20030501), vol. 111, no. 9, ISSN 0021-9738, pages 1287 - 1295, XP002317731 [Y] 1-9 * the whole document * | DOI: | http://dx.doi.org/10.1172/JCI200317929 | Type: | Non-patent literature | Publication information: | [Y] - ERBER RALF ET AL, "Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms", FASEB JOURNAL, FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, US, vol. 18, no. 2, ISSN 0892-6638, (20041204), pages 338 - 340, (20091001), XP002548466 [Y] 1-9 * the whole document * | Type: | Non-patent literature | Publication information: | [Y] - MCCARTY MARYA F ET AL, "ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer.", MOLECULAR CANCER THERAPEUTICS SEP 2004 LNKD- PUBMED:15367698, (200409), vol. 3, no. 9, ISSN 1535-7163, pages 1041 - 1048, XP009133243 [Y] 1-9 * Discussion * |
